WHO

TWiV 576: Big data in virology and public health

From the 22nd meeting of the European Society for Clinical Virology in Copenhagen, Vincent speaks with Thea, Heli, Kim, Caroline and Irma about big data and its increasing use in virology diagnostics, epidemiology, and public health. Click arrow to play Download TWiV 576 (33 MB .mp3, 54 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at …

TWiV 576: Big data in virology and public health Read More »

From trivalent to bivalent oral poliovirus vaccine

For the first time since April of 1955, recipients of poliovirus vaccine will no longer receive all three serotypes. This past Sunday the World Health Organization orchestrated a synchronized switch from trivalent to bivalent oral poliovirus vaccine (OPV) in 150 countries. The reason for the switch is clear: type 2 poliovirus was declared eradicated last year, and the …

From trivalent to bivalent oral poliovirus vaccine Read More »

The switch from trivalent to bivalent oral poliovirus vaccine: Will it lead to polio?

In four months, 155 countries will together switch from using trivalent to bivalent oral poliovirus vaccine. Will this change lead to more cases of poliomyelitis? There are three serotypes of poliovirus, each of which can cause paralytic poliomyelitis. The Sabin oral poliovirus vaccine (OPV), which has been used globally by WHO in the eradication effort, is …

The switch from trivalent to bivalent oral poliovirus vaccine: Will it lead to polio? Read More »

Virologists, start your poliovirus destruction!

I have worked on poliovirus for over thirty-six years, first as a posdoctoral fellow with David Baltimore in 1979, and then in my laboratory at Columbia University. The end of that research commences this year with the destruction of my stocks of polioviruses. In 2015 there were 70 reported cases of poliomyelitis caused by wild …

Virologists, start your poliovirus destruction! Read More »

WHO assessment of experimental Ebola virus vaccines

The World Health Organization held a conference to assess the status of testing and eventual licensing of two candidate Ebola virus vaccines. The agenda and list of participants and the final report are available. I was interested in the following list of key expected milestones: October 2014: Mechanisms for evaluating and sharing data in real time must be …

WHO assessment of experimental Ebola virus vaccines Read More »

Scroll to Top